Reta Beats the S&P
Your triple agonist is compounding faster than your index funds, and the vial hits harder than any dividend.
Filed under Retatrutide · #glp-1 ·#cope ·#stack-life
- RX
- Retatrutide
- Dosage
- $1,200/mo
- Half-life
- until vesting
- Source
- manual
- Tags
- glp-1 , cope , stack-life
- Stamped
- 2026-07-25 · Cycle 030
- Lot #
- LOT-20260725T18:24:32.905Z
